Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

WAKIX (1)

A to Z: Drugs in Highlight: W is for WAKIX®

News A to Z Feature 08/05/2025

Our A to Z series highlights WAKIX® (from Bioprojet Pharma) which is used to treat narcolepsy in adults, adolescents and children from 6 years of age. The active substance in WAKIX® is pitolisant. Pitolisant works by blocking histamine from attaching to the histamine H3 receptor on nerve cells.

Read more
CERDELGA
News, A to Z Feature 04/12/2024

A to Z: Drugs in Highlight: C is for CERDELGA

Secerna Website Images 2023 (63)
European, Industry news, News 03/12/2024

Extension of the European Patent Office’s Patent Prosecution Highway Programme

A To Z Drugs In Highlight B Is For BREO ELLIPTA
Industry news, News, A to Z Feature 28/11/2024

A to Z: Drugs in Highlight: B is for BREO ELLIPTA

Secerna Shares IP Law Insights With Durham University Students
Industry news, News, Careers 26/11/2024

Secerna Sparks Interest in IP Law at Durham University

EPO 2021
European, Industry news, News 19/11/2024

Unitary Patent: Legal provision to implement EU sanctions against Russia

A to Z: Drugs in Highlight: A is for AKEEGA®
News, A to Z Feature 15/11/2024

A to Z: Drugs in Highlight: A is for AKEEGA®

Sweden Aims to Protect Its Brand with Trademark Application
European, Industry news, News 13/11/2024

Sweden Aims to Protect Its Brand with Trademark Application

Celebrating Chemistry Week 2024: Funding Schemes and Support Options
Industry news, News 07/11/2024

Celebrating Chemistry Week 2024: Funding Schemes and Support Options

JROBERTS - Secerna
Events, News 05/11/2024

Secerna to discuss IP at Manufacturing & Engineering North East (MENE)

2 3 4 5 6 7 8 9 10 11 12